Search Results 2071-2080 of 14799 for anti-TNF drugs

1. Science Saturday: Advancing cell-based regenerative therapy for heart failure - Mayo Clinic News Network

   "The safety and efficacy of stem cell therapy have been documented in advanced clinical trials, but the method of cell manufacturing had remained cost- ...

2. A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... [HBsAg] positive) or hepatitis C virus (HCV) (anti-HCV positive).

3. Antithyroid Agent (Oral Route, Rectal Route) Description and Brand Names - Mayo Clinic

   These medicines work by making it harder for the body to use iodine to make thyroid hormone. They do not block the effects of thyroid hormone that was made ...

4. Mefloquine (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

5. Pragmatic Comparative Clinical Trial to Determine Optimal Initial Therapy for Multiple Myeloma

   Previously untreated active multiple myeloma starting a new treatment for their disease with one of the three established treatment regimens: VRd, DRd, or DVRd.

6. Trastuzumab-Anns (Intravenous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

7. Beta-Adrenergic Blocker (Ophthalmic Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

8. A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis - Mayo Clinic

   Past use of any anti-interleukin (IL)-13 or anti-IL-14/IL-13 therapy, including lebrikizumab; Evidence of acute or chronic hepatitis or known liver cirrhosis.

9. Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now - Mayo Clinic

   The five year follow-up period will ensure robust survival data for correlations with clinical, tumor, and treatment variables. The target of 2,500 patients is ...

10. Endurant Stent Graft System vs Excluder Endoprothesis: A Global, Prospective, Randomized Clinical Trial in Sac Regression (ADVANCE Trial) - Mayo Clinic

    About this study. The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems ...